Literature DB >> 26596813

Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More.

Jean-Claude Daubert1, Raphaël Martins2, Christophe Leclercq2.   

Abstract

Both cardiac resynchronization therapy with a pacemaker (CRT-P) and with a biventricular implantable cardioverter-defibrillator (CRT-D) are electrical treatment modalities validated for the management of chronic heart failure. There is no strong scientific evidence that a CRT-D must be offered to all candidates. Common sense should limit the prescription of these costly and complicated devices. The choice of CRT-P is currently acceptable. A direction to explore could be to downgrade from CRT-D to CRT-P at the time of battery depletion in patients with large reverse remodeling and no ventricular tachycardia and ventricular fibrillation detected.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Chronic heart failure; Pacemaker

Mesh:

Year:  2015        PMID: 26596813     DOI: 10.1016/j.ccep.2015.08.016

Source DB:  PubMed          Journal:  Card Electrophysiol Clin        ISSN: 1877-9182


  1 in total

1.  Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study.

Authors:  Simon von Gunten; Dominic A Theuns; Michael Kühne; Tobias Reichlin; Christian Sticherling; Beat Schaer
Journal:  Cardiol J       Date:  2018-11-28       Impact factor: 2.737

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.